Welcome to our dedicated page for Calavo Growers SEC filings (Ticker: CVGW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Calavo Growers, Inc. (NASDAQ: CVGW) SEC filings page on Stock Titan brings together the company’s official U.S. Securities and Exchange Commission disclosures, including 8-K current reports, annual reports on Form 10-K and quarterly reports on Form 10-Q. These documents provide detailed insight into Calavo’s business in the processing and distribution of avocados, tomatoes, papayas and guacamole, as well as its Prepared segment activities.
Recent Form 8-K filings highlight several important developments. On January 14, 2026, Calavo filed an 8-K describing its entry into an Agreement and Plan of Merger with Mission Produce, Inc., under which Mission will acquire Calavo in a cash and stock transaction, subject to shareholder approvals, regulatory clearances and other customary conditions. Other 8-Ks disclose matters such as the retirement of senior executives, the appointment and compensation terms of a new President and Chief Executive Officer, the formation of a Special Transactions Committee to review strategic alternatives, and the conclusion of an SEC staff investigation without an enforcement recommendation.
Additional filings document earnings announcements by furnishing press releases that discuss quarterly and annual financial results, including segment performance, non-GAAP measures like adjusted EBITDA and adjusted net income, and explanations of discrete costs such as those related to an FDA detention hold on certain avocado imports from Mexico. Calavo also uses its SEC reports to describe legal and regulatory matters, tax-related developments in Mexico, and its dividend policy.
On Stock Titan, these filings are updated in near real time from the SEC’s EDGAR system. AI-powered summaries help explain lengthy documents, highlighting key items such as revenue trends, segment results, merger terms, executive compensation arrangements and risk disclosures. Investors can also review insider and equity-related information referenced in filings, including stock option and restricted stock unit terms described in compensation agreements and equity plans. This page offers a structured way to analyze Calavo’s regulatory history, financial reporting practices and major corporate events directly from its official SEC submissions.
Calavo Growers, Inc. reported that at a special shareholder meeting on April 28, 2026 shareholders approved the Agreement and Plan of Merger with Mission Produce, Inc., as described in the companies' joint proxy statement/prospectus. A total of 13,082,457 shares were present or represented by proxy (approximately 73.19% of outstanding).
The record date for the meeting was March 16, 2026, when 17,874,079 shares of common stock were outstanding. The non-binding advisory proposal on merger-related executive compensation did not receive the requisite shareholder support. Closing of the Mergers is expected during the fiscal quarter ending July 31, 2026, subject to regulatory approvals in Mexico and other customary closing conditions; Calavo common stock is expected to be halted and delisted upon closing.
Calavo Growers, Inc. shareholders approved the Agreement and Plan of Merger with Mission Produce, Inc. at a special meeting held on April 28, 2026. The merger will occur through a two-step structure in which Calavo is first merged into a Mission subsidiary and then into a second Mission entity.
Of 17,874,079 shares entitled to vote, 13,082,457 shares were present, and the merger agreement received 12,110,759 votes in favor. A separate, non-binding advisory proposal on merger-related executive compensation did not pass. Closing still depends on regulatory approvals in Mexico, and Calavo’s Nasdaq listing is expected to end once the mergers close.
CALAVO GROWERS INC Chief Executive Officer Bruce John Lindeman reported equity compensation-related transactions involving company stock. On April 23, 2026, he exercised derivative awards classified as restricted stock units to acquire 4,259 shares of common stock at an exercise price of $0.0000 per share.
On the same date, 1,587 shares of common stock were disposed of in a tax-withholding transaction at $27.86 per share to cover obligations tied to the award. After these transactions, Lindeman directly held 24,556 shares of CALAVO GROWERS INC common stock. Footnotes also describe separate restricted stock units representing a contingent right to receive 2,220 shares of common stock, which fully vested earlier with receipt deferred under the award agreement.
CALAVO GROWERS INC director J. Link Leavens exercised equity awards and updated his holdings. On April 23, 2026, he exercised 4,259 Restricted Stock Units, receiving the same number of common shares at a stated price of $0.00 per share.
After this exercise, Leavens directly owns 89,858 shares of common stock. He also indirectly owns 266,413 shares held in the names of various partnerships where he shares voting and investment power, as described in the footnotes. Each restricted stock unit represents a contingent right to receive one Calavo common share, with vesting tied to a one-year anniversary of grant or the company’s 2026 annual meeting of shareholders.
Calavo Growers director Kathleen M. Holmgren reported the vesting and exercise of restricted stock units into common stock. She acquired 4,259 shares of Calavo Growers common stock at a price of $0.00 per share through a derivative exercise, bringing her direct ownership to 26,950 shares. The corresponding 4,259 restricted stock units, each representing a contingent right to receive one share, were reduced to zero, reflecting a routine equity compensation event rather than an open-market trade.
Calavo Growers director Michael Anthony DiGregorio exercised 4,259 restricted stock units into common stock. Each unit represented a right to receive one Calavo share, and this exercise increased his direct common stock holdings to 39,450 shares following the transaction.
Director Marc Laurence Brown of Calavo Growers Inc exercised restricted stock units into common shares. He converted 4,259 restricted stock units into 4,259 shares of common stock, with no cash exercise price reported. Following this transaction, he directly holds 32,700 shares of Calavo common stock. The filing shows no remaining derivative position from these restricted stock units, indicating they have been fully converted into shares.
Calavo Growers Inc director Adriana Mendizabal exercised restricted stock units into common shares. On April 23, 2026, she exercised 4,259 restricted stock units at an exercise price of $0.00 per unit, receiving 4,259 shares of common stock.
After this transaction, she directly holds 15,480 shares of Calavo common stock. Footnotes explain that each restricted stock unit represents a contingent right to receive one share of CVGW common stock and that a separate block of 2,220 restricted stock units relates to common shares whose receipt was previously deferred.
Calavo Growers director Steve Hollister exercised 4,259 restricted stock units, receiving the same number of common shares at a stated price of $0.00 per share. Following the transaction, he directly holds 48,110 shares of Calavo Growers common stock.
Each restricted stock unit represents a contingent right to receive one share of common stock and fully vests on the earlier of the one-year anniversary of the grant date or Calavo Growers’ 2026 annual meeting of shareholders, provided that meeting occurs on or after April 8, 2026.
Mission Produce, Inc. reported that the Hart-Scott-Rodino waiting period for its previously announced merger with Calavo Growers expired at 11:59 p.m. Eastern on April 17, 2026, satisfying one closing condition. The Mergers remain subject to stockholder approvals, Mexican antitrust clearance and other customary closing conditions. The parties expect to close in the fiscal quarter ending July 31, 2026. Mission filed a Registration Statement on Form S-4 (declared effective March 20, 2026) and commenced mailing the Joint Proxy Statement/Prospectus on or about March 25, 2026.